PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

$73.31
+2.46 (+3.47%)
As of Aug 7, 8:11 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 17 81%
Hold 3 14%
Sell 1 5%
Price Target
Analyst Price Target +6.4% upside
Low Target $54.55
Average Target $77.98
High Target $125.35
Current Price $73.31
Current
$73.31
Target
$77.98
$54.55 $77.98 avg $125.35
Scenario Analysis
Bear Case
$54.55
-25.6%
Low target
Base Case
$77.98
+6.4%
Avg target
Bull Case
$125.35
+71.0%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$90.87
-19.3% from high
52-Week Low
$43.18
+69.8% from low
50-Day SMA
$75.08
-2.4% vs SMA
200-Day SMA
$61.55
+19.1% vs SMA
RSI (14)
25.1
Oversold
Target vs 52W High
$77.98
-14.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +5.0%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +171.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -43.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.3%
BIIB
Biogen Inc
Buy 44 64% $91.45 -55.7%